Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Financial Advisory House (FAH) is a prominent Saudi Arabian investment banking and financial services firm headquartered in Riyadh. Licensed by the Capital Market Authority (CMA), the company provides a comprehensive suite of services including corporate finance advisory, mergers and acquisitions (M&A), and wealth management. FAH has a significant track record in the Middle Eastern market, where it specializes in structuring Sharia-compliant financial products and facilitating initial public offerings (IPOs) for regional enterprises. While the firm is not a biotechnology developer, it frequently advises companies in the healthcare and pharmaceutical sectors on strategic capital raises and financial restructuring. Its expertise is particularly focused on the Saudi Arabian market, supporting the growth of private healthcare infrastructure and industrial services in the GCC region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Financial Advisory House.